BIOMAT Database Logo BIOMAT Database Logo

Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. 2009

Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic
D053208 Kaplan-Meier Estimate A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995) Kaplan-Meier Survival Curve,Kaplan-Meier Analysis,Kaplan-Meier Survival Curves,Kaplan-Meier Test,Product-Limit Method,Analysis, Kaplan-Meier,Curve, Kaplan-Meier Survival,Curves, Kaplan-Meier Survival,Estimate, Kaplan-Meier,Kaplan Meier Analysis,Kaplan Meier Survival Curve,Kaplan Meier Survival Curves,Kaplan Meier Test,Method, Product-Limit,Methods, Product-Limit,Product Limit Method,Product-Limit Methods,Survival Curve, Kaplan-Meier,Survival Curves, Kaplan-Meier,Test, Kaplan-Meier
D018040 Receptors, Neurokinin-1 A class of cell surface receptors for TACHYKININS with a preference for SUBSTANCE P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells. NK-1 Receptors,Neurokinin-1 Receptors,Receptors, Substance P,SP-P Receptors,Substance P Receptors,NK-1 Receptor,Neurokinin-1 Receptor,Receptors, NK-1,Receptors, SP-P,SP-P Receptor,Substance P Receptor,Substance-P Receptor,Tachykinin Receptor 1,NK 1 Receptor,NK 1 Receptors,Neurokinin 1 Receptor,Neurokinin 1 Receptors,P Receptor, Substance,P Receptors, Substance,Receptor, NK-1,Receptor, Neurokinin-1,Receptor, SP-P,Receptor, Substance P,Receptor, Substance-P,Receptors, NK 1,Receptors, Neurokinin 1,Receptors, SP P,SP P Receptor,SP P Receptors
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
October 2017, Research in veterinary science,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
January 2016, OncoTargets and therapy,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Substance P and its receptor neurokinin 1 expression in asthmatic airways.
October 2000, The Journal of allergy and clinical immunology,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer.
July 2022, Cancers,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Involvement of the substance P/neurokinin-1 receptor system in oral pain and inflammation.
January 2020, Journal of biological regulators and homeostatic agents,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer.
October 2022, Reports of biochemistry & molecular biology,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Substance P and neurokinin-1 receptor modulation of HIV.
December 2004, Journal of neuroimmunology,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
July 2012, Journal of cellular and molecular medicine,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
December 2012, Peptides,
Francisco Esteban, and Miguel Angel Gonzalez-Moles, and David Castro, and Maria del Mar Martin-Jaen, and Maximino Redondo, and Isabel Ruiz-Avila, and Miguel Muñoz
Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.
November 2000, The American journal of pathology,
Copied contents to your clipboard!